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PURPOSE. To quantify the human corneal inflammatory re-
sponse in treated bacterial keratitis with long-wavelength an-
terior segment optical coherence tomography (AS-OCT).
METHODS. Patients with clinically suspected bacterial keratitis
were recruited from the corneal service at Southampton Eye
Unit, UK. Patients underwent AS-OCT and slit-lamp examina-
tion on presentation (day 0) and days 3, 7, and 14 of treatment.
Corneal thickness (CT) in the infiltrated area, infiltrate thick-
ness (IT), and infiltrate width (IW) were measured on high-
resolution AS-OCT scans. Mean values for each day and rates of
change for each interval were calculated and compared (one-
way ANOVA, paired t-test).
RESULTS. Twenty-six eyes of 26 patients were recruited. Mean
CT and IT on presentation were 905 m and 388 m, respec-
tively. On days 3, 7, and 14, CT and IT decreased to 753 m
and 320 m (P  0.01), 678 m and 296 m (P  0.01), and
584 m and 207 m (P  0.01), respectively. Mean IW, 1498
m on presentation, did not change during treatment (P 
0.30). Mean daily rate of CT reduction was faster in the early
(days 0–3) compared to late (days 7–14) phase (4.49% vs.
1.33%, P  0.006). Mean daily rate of IT reduction was no
different in early, middle, and late phases (5.41% vs. 1.19% vs.
3.38%, P  0.01). In the late phase, IT decreased faster than CT
(3.38% vs. 1.33%, P  0.003).
CONCLUSIONS. CT and IT decreased significantly by day 3 in
resolving bacterial keratitis. The rapid early phase reduction in
IT and CT was followed by rapid late phase IT reduction. This
study demonstrates that serial AS-OCT examination can be
used to monitor in vivo the clinical course of inflammatory
disease. (Invest Ophthalmol Vis Sci. 2011;52:1093–1097) DOI:
10.1167/iovs.10-6067
Corneal disease is a major cause of blindness, with itsepidemiology encompassing a spectrum of corneal infec-
tions and inflammatory diseases.1–4 Bacterial keratitis, an infec-
tive and inflammatory condition of the cornea, is characterized
by corneal epithelial ulceration, corneal edema and stromal
infiltration with inflammatory cells.5–8 Animal studies have
confirmed these morphologic changes with histopathol-
ogy.6,9,10
In clinical practice, bacterial keratitis is routinely assessed
with slit-lamp biomicroscopy, an examination and imaging
modality that is primarily limited by the physical properties of
light. The location of corneal infiltration can be assessed and
the horizontal and vertical dimensions of epithelial ulceration
and infiltration measured.11 However, the depth of pathology
and associated corneal edema cannot be measured with the
slit-lamp. As a result, in vivo information regarding corneal
inflammation in bacterial keratitis and the response to treat-
ment is limited.
Objective clinical assessment of bacterial keratitis and the
treatment response is difficult, especially during the early treat-
ment phase. Subjective features, such as improvement of pa-
tient symptoms, are therefore also used as indicators of resolv-
ing infection. Recently, however, in vivo assessment of
microbial keratitis has become possible with long wavelength
anterior segment optical coherence tomography (AS-OCT).
This modality provides cross-sectional scans of the cornea and
assessment of the depth of inflammation with measurements of
stromal infiltration thickness and corneal thickness in the infil-
trated area.12
In this study we aim to quantify corneal inflammation in
resolving bacterial keratitis by measuring the temporal in vivo
change of corneal thickness (CT), infiltrate thickness (IT), and




This study was approved by the local NHS Research Ethics Committee
and informed consent was obtained from all patients. The research was
performed in accordance with the tenets of the Declaration of Hel-
sinki. Subjects with a clinical diagnosis of presumed bacterial keratitis
were recruited from the corneal service at Southampton Eye Unit,
Southampton University Hospitals NHS Trust, UK. A clinical diagnosis
of bacterial keratitis was made in the presence of a typical history and
an epithelial ulceration with underlying stromal infiltration associated
with signs of inflammation.13–15 Patients with a history and clinical
findings suggestive of a viral keratitis or hypersensitivity type corneal
ulceration were not recruited. Bacterial keratitis was considered re-
solved if the epithelial defect and signs of inflammation resolved
completely. Recruited patients who did not respond to antibacterial
treatment were excluded.
Examination and Scanning Protocol
Anterior segment imaging was carried out by OCT tomography
(Visante OCT; Carl Zeiss Meditec Inc, Dublin, CA). AS-OCT imaging
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and clinical slit-lamp examination were carried out on presentation
(day 0) and subsequently on days 3, 7, and 14 of treatment. All patients
underwent treatment based on clinical findings and requirements.
Standard antibacterial treatment was intensive guttae ofloxacin 0.3%
and guttae cefuroxime 5% to the affected eye. Antibiotics were instilled
at an hourly frequency for 48 hours, then reduced to two hourly for a
further 48 hours. The frequency was then reduced to six hourly for a
total treatment period of two weeks.
A standardized scanning protocol was used. At all visits high-
resolution AS-OCT scans were carried out through the same area of
corneal infiltration with the scanning beam running through the center
of the infiltration at a defined axis. Corneal infiltration on the AS-OCT
images was defined as the hyper-reflective area that corresponded to
the clinical corneal infiltration. CT, IT, and IW were measured with
caliper tools of the OCT tomography software (Visante, version 1.1.2;
Carl Zeiss MediTec, Inc.). CT was measured in the center of the
infiltration with one caliper arm on the most anterior hyper-reflective
corneal surface and the second arm on the hyper-reflective endothe-
lium. IT, also in the center of the infiltration, was measured with one
caliper arm on the most anterior hyper-reflective corneal surface and
the second arm on the posterior border of the hyper-reflective area. IW
was measured by placement of the caliper arms on the transverse
borders of the hyper-reflective area. The scanning protocol is illus-
trated in Figure 1.
CT, IT and IW were measured on days 0 (presentation), 3, 7, and 14
of treatment. Mean values were calculated for each day and compared.
For parameters that showed statistically significant change, the daily
rate of change was calculated for the early (days 0 to 3), middle (days
3 to 7), and late (days 7 to 14) phases of treatment. Daily rate of change
of each parameter was calculated for each eye according to the for-
mula: [X day B  X day A] /X day A /time interval in days, where X is
the parameter value and A and B are the first and last day of the
treatment phase, respectively. Mean values were calculated and com-
pared.
Statistical Analysis
Power of the study to detect rate of change in IT and CT, at 5%
significance level, using one-way analysis of variance (ANOVA) was
93% and 92%, respectively. Mean values of CT, IT, IW and their daily
rate of change were compared for statistical difference using paired
t-test and one-way ANOVA. P values  0.01 were considered statisti-
cally significant. Statistical Analysis was performed with analysis soft-
ware (The Statistical Package for Social Science, version 15; SPSS Inc,
Chicago, IL).
RESULTS
Twenty seven patients (27 eyes) with a clinical diagnosis of
bacterial keratitis were recruited. One patient who did not
respond to standard antibacterial treatment had fungal keratitis
and was excluded. In the remaining 26 patients with bacterial
keratitis the infection resolved. Patient and keratitis character-
istics are summarized in Table 1. Serial AS-OCT imaging and the
change in CT, IT and IW with treatment are illustrated in
Figures 1 and 2.
CT in the infiltrated area was largest on presentation (day 0)
with a mean [SD] value of 905 [206] m. On days 3, 7, and 14
mean [SD] CT had decreased significantly to 753 [161] m













Contact lens wear 20
Recurrent corneal erosion syndrome 2
Lagophthalmos 2
Atopy with dry eye 1















OCT, optical coherence tomography.
FIGURE 1. AS-OCT imaging of bacterial keratitis. (A) A corneal ulcer
with inflammatory infiltration (4) due to Pseudomonas aeruginosa
keratitis. (B) The high-resolution AS-OCT image through the center of
the infiltrated area at the 165° axis on presentation. The hyper-reflec-
tive area in the anterior corneal stroma corresponds to the clinical
infiltration. The epithelium and endothelium have lost the smooth
profile, reflecting the increased stromal thickness due to stromal infil-
tration and edema. Corneal thickness, infiltrate thickness and infiltrate
width measure 1130, 540, and 1690 m respectively. (C), (D), and (E)
illustrate the reduction of corneal and infiltrate thickness on days 3, 7,
and 14 respectively. Infiltrate width does not change considerably.
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(P  0.001), 678 [178] m (P  0.001) and 584 [146] m
(P  0.001), respectively. CT measurements were possible
in all 26 (100%) eyes. The temporal change of CT is illus-
trated in Figure 3.
IT was also largest on presentation with a mean [SD] value
of 388 [184] m. On days 3, 7, and 14, mean [SD] IT had
decreased to 320 [163] m (P  0.001), 296 [135] m (P 
0.004), and 207 [87] m (P  0.001), respectively. IT mea-
surements could be carried out in 21 (80.8%) of cases. The
temporal change of IT is illustrated in Figure 4.
Mean [SD] IW on presentation was 1530 [1048] m. IW did
not change significantly during treatment with mean [SD] values
of 1498 [855] m (P  0.591), 1547 [956] m (P  0.878), and
1680 [1014] m (P  0.308), on days 3, 7, and 14 respectively.
IW measurements were possible in 13 (50%) eyes (Fig. 5).
CT decreased most rapidly in the early phase of treatment,
with a mean [SD] daily rate of 4.49 [3.78]%. The mean [SD]
daily rate of CT reduction in the middle phase was 2.69 [3.62]%
(4.49 vs. 2.69, P  0.21) and decreased in the late phase to
1.33 [2.29]% per day (4.49 vs. 1.33, P  0.006).
IT also decreased most rapidly in the early phase of treat-
ment, with a mean [SD] daily rate of 5.41 [5.13]%. In the
middle phase, the mean [SD] daily rate of IT reduction was
slower at 1.19 [6.80]% (5.41 vs. 1.19, P  0.042), but acceler-
ated again in the late phase to 3.38 [3.08]% per day (5.41 vs.
3.38, P  0.70).
The mean daily rates of CT and IT reduction were not
significantly different in the early (4.49% vs. 5.41%, P  0.49)
and middle phases of treatment (2.69 vs. 1.19, P  0.40). In the
late phase, however, IT decreased at a significantly faster rate
than CT (3.38% vs. 1.33%, P  0.003; Table 2).
Pseudomonas aeruginosa was cultured in 9 cases. A sub-
group analysis was therefore carried out to compare pseu-
domonas to non-pseudomonas keratitis. CT on presentation
was larger in the pseudomonas group (mean CT [SD]: 1072
[196] vs. 807 [142] m, P  0.001), as was IT (mean IT [SD]:
501 [117] vs. 344 [189] m, P  0.057), and IW (mean IW
[SD]: 2628 [1057] vs. 1035 [565] m, P  0.003). CT and IT
differences between the two pathogen groups did not persist
on days 3, 7, and 14. The IW difference persisted on day 3
(mean IW [SD]: 2460 [894] vs. 1138 [566] m, P  0.009), day
7 (mean IW [SD]: 2660 [927] vs. 1052 [391] m, P  0.001),
and day 14 (mean IW [SD]: 2655 [873] vs. 1167 [649] m, P 
0.005) of treatment.
FIGURE 2. Culture-negative keratitis
imaged serially with AS-OCT show-
ing the change in corneal parameters
in a contact lens wearer with pre-
sumed bacterial keratitis. Serial high-
resolution AS-OCT scans have been
carried out through the center of the
corneal infiltration at the 174° axis.
(A) The stromal infiltration Š at pre-
sentation associated with posterior
bowing of the endothelium due to
infiltration and edema. Corneal thick-
ness, infiltrate thickness and infiltrate
width measure 750, 250, and 1100
m respectively. (B), (C), and (D)
illustrate the reduction of corneal
and infiltrate thickness on days 3, 7,
and 14 of treatment. Infiltrate width
does not decrease.
FIGURE 3. Corneal thickness reduction during treatment of bacterial
keratitis.
FIGURE 4. Infiltrate thickness reduction during treatment of bacterial
keratitis.
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The rate of decrease of CT was statistically larger in the
pseudomonas group during the early treatment phase (mean
[SD] daily rate: 7.58 [4.57] vs. 3.22 [2.61]%, P  0.007), but of
borderline statistical difference in the middle (mean [SD] daily
rate: 4.48 [3.66] vs. 1.74 [3.32]%, P  0.09) and late (mean
[SD] daily rate: 2.18 [1.61] vs. 0.78 [2.54] %, P  0.16) phases.
The rate of decrease of IT was not statistically different in the
two groups.
DISCUSSION
In this quantification study of human bacterial keratitis both CT
and IT decreased significantly within three days of starting
treatment, providing objective evidence that successful treat-
ment results in an early reduction in corneal edema and inflam-
mation. In contrast, IW did not change. This study has also
shown that AS-OCT can be applied to the in vivo quantification
of the course of an inflammatory condition, providing serial
measurements of CT, IT, and IW in bacterial keratitis.
In addition to this early phase reduction in IT and CT,
resolving bacterial keratitis showed a late phase reduction in
IT. During the early and middle phases of treatment, IT and CT
decreased at similar rates, indicating that a similar process may
be taking place in the infiltrated and deeper non-infiltrated
cornea. Reduction in corneal edema is the most likely expla-
nation for these early changes. In the late phase, however, the
reduction of CT decelerated significantly compared to the early
phase and IT decreased at a significantly faster rate than CT.
This suggests a different biological process to the early phase.
We hypothesize that resolution of inflammatory cells and other
components of the stromal infiltrate takes place in this late
phase.
Pseudomonas keratitis had a larger corneal inflammatory
response than non-pseudomonas keratitis. All parameters, CT,
IT, and IW, were larger in corneal infection due to pseudomo-
nas. In addition, early CT reduction was more rapid in this
group. Histopathology studies have shown that inflammation
in bacterial keratitis is characterized by stromal infiltration and
corneal edema.6,9,10 Experimental animal models of pseu-
domonas keratitis have shown intense PMN infiltration and
edema on light microscopy.10,16 The in vivo quantitative and
morphologic information provided by AS-OCT is consistent
with these microscopy examinations. AS-OCT technology,
however, does not have the capability to distinguish inflamma-
tory infiltration from scarring, as both appear hyper-reflective
on AS-OCT.
In animal studies of keratitis, in vivo assessment of the
infection severity and course is carried out with slit-lamp grad-
ing. Ocular parameters, such as conjunctival injection, chemo-
sis, corneal infiltration, corneal edema, and iritis are quantified
on a grading scale of 0 to 4 to produce a total severity score.6
Enucleation of the eye and microscopy examination are often
required to objectively assess the extent and depth of corneal
infection.9,10 The development of a portable AS-OCT device
may overcome these limitations and provide objective in vivo
quantification information without the requirement for enucle-
ation.
We found that IW, as defined in this study, did not decrease
with resolution of the infection. This may be explained by the
proximity of the superficial margins of the infiltrated area to
the immune laden tear film and limbus. In the early phase of
treatment, any reduction in edema is offset by a waning im-
mune response that is more likely to infiltrate the superficial
margins rather than the compact deeper stroma. In the later
phases, as the inflammatory components are gradually re-
placed with collagen and scar tissue, the measured width of the
infiltrate would not change, as co-existing scar tissue and
inflammatory infiltration both appear hyper-reflective on AS-
OCT.
We could measure CT in all cases and IT in 80.8% of cases.
However, IW could only be measured in 50% of cases, as the
transverse margins of the infiltrate could not be identified in
the remaining cases. This is most likely due to two factors.
First, infiltrations have soft, ill-defined transverse margins from
ongoing inflammatory activity, and second, the AS-OCT trans-
verse imaging resolution (60 m) is lower than the axial reso-
lution (18 m).17
This study has also demonstrated the application of AS-OCT
to monitoring bacterial keratitis in clinical practice. Reiterative
scans and measurements of CT, IT, and IW can be used for
objective and quantitative assessment of disease severity and
treatment response. Although slit-lamp biomicroscopy is the
gold standard in clinical practice, evaluation of corneal inflam-
mation is subjective and assessment of the treatment response
is difficult in the early stages. AS-OCT showed a mean IT
reduction of 68 m in the early phase, a change that cannot be
FIGURE 5. Infiltrate width in resolving bacterial keratitis.
TABLE 2. Rate of Change of Corneal Thickness and Infiltrate Thickness in Resolving Bacterial Keratits
Rate of Change (% per day) Days 0–3 Days 3–7 Days 7–14
Mean daily CT decrease [SD] 4.49 [3.78] 2.69 [3.62] 1.33 [2.29]
Mean daily IT decrease [SD] 5.41 [5.13] 1.19 [6.80] 3.38 [3.08]
P* 0.49 0.40 0.003
CT, corneal thickness; IT, infiltrate thickness.
* P: 2-tailed t-test.
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detected or measured with slit-lamp biomicroscopy. The use of
long wavelength light (1310 nm) in AS-OCT achieved good
penetration through structures that highly scatter light, such as
corneal infiltration and opacification, by non-contact examina-
tion.12,18,19 Alternative imaging modalities, such as ultrasound
biomicroscopy and Scheimpflug imaging (Pentacam), have a
limited role in corneal inflammation.
In summary, AS-OCT can directly visualize, measure and
monitor in vivo parameters of corneal inflammation in bacterial
keratitis. Resolving corneal infection is characterized by an
early reduction in corneal edema, followed by a later reduction
in infiltration. Serial standardized AS-OCT scanning can be used
in clinical practice to quantify and objectively assess bacterial
keratitis.
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